About Abrogate Pharma Llp
Abrogate Pharma Llp is a Limited Liability Partnership company and was incorporated on Aug 21, 2020 in India. It is registered at Registrar of Companies, ROC Jaipur. Its registered address is 7 CH 25, Jawahar Nagar, Jaipur, Jaipur, Rajasthan, India, 302004. Its corporate identification number is (CIN) AAT-4347 and its current status is Active. Its industry classification as per MCA is manufacture Of Chemicals And Chemical Products.
Abrogate Pharma Llp generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2022.
Key Metrics
CIN
AAT-4347
Location
Current Status
Active
Entity Type
Limited Liability Partnership
Date Of Incorporation
Aug 21, 2020
Company Age
6 Years 1 Month
Registrar of Companies
ROC - Jaipur
Latest Revenue
0 - ₹10 Cr as on Mar 31, 2022
Contact Details for Abrogate Pharma Llp
- *****@gmail.com
- Registered Address
- 7 CH 25, Jawahar Nagar, Jaipur, Jaipur, Rajasthan, India, 302004
Documents of Abrogate Pharma Llp15 mins
15 minsRecent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
LLP Form11 | Annual Returns and Balance Sheet eForms | Jun 25, 2024 |
LLP Form11 | Annual Returns and Balance Sheet eForms | May 30, 2023 |
LLP Form8 | Annual Returns and Balance Sheet eForms | Nov 01, 2022 |
LLP Form8 | Charges | Nov 01, 2022 |
LLP Form11 | Annual Returns and Balance Sheet eForms | Jul 11, 2022 |
LLP Form8 | Annual Returns and Balance Sheet eForms | Dec 30, 2021 |
LLP Form8 | Charges | Dec 30, 2021 |
LLP Form11 | Annual Returns and Balance Sheet eForms | Jul 29, 2021 |
Certificate of Incorporation | Certificates | Aug 19, 2020 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings 15 mins
Financials of Abrogate Pharma Llp15 mins
Abrogate Pharma Llp generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2022. The revenue of Abrogate Pharma Llp has a compounded annual growth rate (CAGR) of 906% in the last 1 year.
Financial Statement Summary
Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
Income Statement | ||
Revenue | 9674 | 4951 |
EBITDA | 7419 | 7006 |
Net Profit | 3977 | 9472 |
Balance Sheet | ||
Assets | 1904 | 1722 |
Liabilities | 7633 | 2344 |
To access detailed financial performance and data, Buy Financial Report 15 mins
Ratios
Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
Profitability Ratios | ||
EBITDA Margin | 4237 | 3446 |
Net Profit Margin | 7699 | 1098 |
Return on Assets (ROA) | 8909 | 7782 |
Efficiency Ratios | ||
Asset Turnover | 4957 | 7436 |
Liquidity Ratios | ||
Current Ratio | 2118 | 1821 |
Quick Ratio | 8166 | 6877 |
Growth Ratios | ||
Revenue Growth Rate (CAGR) | 9345 | 4159 |
Earnings Growth Rate (CAGR) | 9957 | 4430 |
To access detailed financial performance and data, Buy Financial Report 15 mins
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of Abrogate Pharma Llp
Revenue CAGR | Growth |
|---|---|
1 Year | 906% |
3 Year | 183 |
5 Year | 215 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 121% |
3 Year | 747 |
5 Year | 172 |
MSME Payment Delays by Abrogate Pharma Llp
GSTIN Details of Abrogate Pharma Llp
Legal Cases involving Abrogate Pharma Llp
FAQs about Abrogate Pharma Llp
Explore our recently published Legal Entities
